Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 256940208 approvals3 trials

Keeps Biopharma Inc.

Official website

Founded in 2000 and listed on KOSDAQ in 2017, Keeps Biopharma transitioned from OLED equipment to pharmaceuticals through its 2025 merger with Korea Global Pharm.

As of 2026-10-10, Keeps Biopharma Inc. has 2 Korean MFDS device approvals, 206 Korean MFDS drug approvals on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Products & technology

  • Globdexy Tab. (dexibuprofen)Anti-inflammatory analgesic
  • Globsta Tab. (atorvastatin calcium hydrate)Lipid-lowering agent
  • OraloidOral delivery platform for peptide therapeutics (insulin, GLP-1, PTH)

Regulatory approvals

data.go.kr

206 Korean MFDS drug approvals · 1999–2026 / 2 Korean MFDS device approvals · 2023–2024

  • MFDS drugRovaampin Tab. 5/5mg2026-04-03
    Drug · Prescription · Approval202600950
  • MFDS drugRovaampin Tab. 10/5mg2026-03-30
    Drug · Prescription · Approval202600884
  • MFDS drugRovaampin Tab. 20/5mg2026-03-30
    Drug · Prescription · Approval202600885
  • MFDS drugNAD Tab.2026-01-19
    Drug · OTC · Notification202600160
  • MFDS drugTopami Tab. 25mg2025-03-31
    Drug · Prescription · Approval202500741
  • MFDS drugMyborn Tab.2025-03-18
    Drug · OTC · Notification202500613
  • MFDS drugVentiMeganice Tab.2025-02-03
    Drug · OTC · Notification202500212
  • MFDS drugGlogingko Tab. 240mg (Ginkgo Leaf Dried Extract)2024-10-14
    Drug · OTC · Notification202402424
  • MFDS drugGloCaID Tab.2024-07-29
    Drug · OTC · Notification202401821
  • MFDS drugRomantin Tab. 20mg2024-07-11
    Drug · Prescription · Approval202401709
  • MFDSSubsidiary: ㈜빅씽크Dressing, fluid-impermeable film2024-03-13
    Product approval · Class 2수인 24-115 호
  • MFDSSubsidiary: ㈜빅씽크Dressing, fluid-impermeable film2023-05-08
    Product approval · Class 2수인 23-4570 호
Show 68 more
  • MFDS drugGlositaformin Tab. 50/1000mg2023-03-13
    Drug · Prescription · Approval202300845
  • MFDS drugGlositaformin Tab. 50/850mg2023-03-13
    Drug · Prescription · Approval202300846
  • MFDS drugGlositaformin Tab. 50/500mg2023-03-13
    Drug · Prescription · Approval202300847
  • MFDS drugGlositaformin SR Tab. 50/500mg2023-02-17
    Drug · Prescription · Approval202300606
  • MFDS drugGlositaformin SR Tab. 50/1000mg2023-02-17
    Drug · Prescription · Approval202300607
  • MFDS drugGlositaformin SR Tab. 100/1000mg2023-02-17
    Drug · Prescription · Approval202300608
  • MFDS drugAdikarb Tab. 30/2.5mg2023-01-06
    Drug · Prescription · Approval202300083
  • MFDS drugAdikarb Tab. 60/5mg2023-01-06
    Drug · Prescription · Approval202300093
  • MFDS drugAdikarb Tab. 60/2.5mg2023-01-06
    Drug · Prescription · Approval202300118
  • MFDS drugGlofen Inj.2022-06-07
    Drug · Prescription · Notification202202367
  • MFDS drugRMS Arginin Solution2022-05-30
    Drug · OTC · Notification202202287
  • MFDS drugDobes Tab. 500mg2022-01-10
    Drug · Prescription · Approval202200188
  • MFDS drugTopami tablets 100mg2021-10-26
    Drug · Prescription · Approval202107135
  • MFDS drugSubsidiary: ㈜빅씽크Nerlynx Tablet (neratinib maleate)2021-10-19
    Drug · Prescription · Approval202107016
  • MFDS drugGlositagle Tab. 25mg(Sitagliptin hydrochloride monohydrate)2021-03-31
    Drug · Prescription · Approval202102830
  • MFDS drugGlositagle Tab. 50mg( Sitagliptin hydrochloride monohydrate)2021-03-31
    Drug · Prescription · Approval202102831
  • MFDS drugGlositagle Tab. 100mg(Sitagliptin hydrochloride monohydrate)2021-03-31
    Drug · Prescription · Approval202102832
  • MFDS drugEMpa Tab. 10mg2021-03-05
    Drug · Prescription · Approval202102097
  • MFDS drugEMpa Tab. 25mg2021-03-04
    Drug · Prescription · Approval202102033
  • MFDS drugEMpa Tab. 10mgRevoked2021-03-04
    Drug · Prescription · Approval202102034
  • MFDS drugGlozet Tab. 10/10mg2021-02-18
    Drug · Prescription · Approval202101421
  • MFDS drugGlozet Tab. 10/20mg2021-02-18
    Drug · Prescription · Approval202101422
  • MFDS drugPret Eye Drops2021-01-14
    Drug · Prescription · Notification202100394
  • MFDS drugLevohi Eye Drops 1.5%2021-01-04
    Drug · Prescription · Approval202100015
  • MFDS drugDapa Tab. 10mg(Dapagliflozin)Revoked2020-12-15
    Drug · Prescription · Approval202008794
  • MFDS drugGlotica Tab. 90mg(Ticagrelor)Revoked2020-11-11
    Drug · Prescription · Approval202007772
  • MFDS drugGlotica Tab. 60mg(Ticagrelor)Revoked2020-10-16
    Drug · Prescription · Approval202007097
  • MFDS drugTapadine Eye Drops 0.2%(single use)2020-10-08
    Drug · Prescription · Approval202006848
  • MFDS drugS-Vil Ibu Soft Cap. 200mg2020-06-29
    Drug · OTC · Notification202004710
  • MFDS drugGlarmac Tab.Revoked2020-05-29
    Drug · Prescription · Approval202004101
  • MFDS drugGlomega Soft Cap.2020-05-29
    Drug · Prescription · Approval202004108
  • MFDS drugUmero Tab. 20/20mg2020-05-28
    Drug · Prescription · Approval202003953
  • MFDS drugUmero Tab. 20/10mg2020-05-28
    Drug · Prescription · Approval202003954
  • MFDS drugUmero Tab. 20/5mg2020-05-28
    Drug · Prescription · Approval202003955
  • MFDS drugTamlos SR cap. 0.4mg2020-04-22
    Drug · Prescription · Approval202002881
  • MFDS drugBrolase Enteric Coated Tab.2020-04-10
    Drug · OTC · Notification202002542
  • MFDS drugGlophylline Cap.Revoked2020-04-02
    Drug · Prescription · Approval202002297
  • MFDS drugAllertin Tab. 10mgRevoked2020-03-25
    Drug · Prescription · Approval202002070
  • MFDS drugAllertin Tab. 20mgRevoked2020-03-25
    Drug · Prescription · Approval202002071
  • MFDS drugGlatidine Tab.Revoked2020-03-20
    Drug · Prescription · Approval202002003
  • MFDS drugDobes Tab.2020-03-18
    Drug · Prescription · Approval202001903
  • MFDS drugPgalin Cap. 75mg2020-02-21
    Drug · Prescription · Approval202001235
  • MFDS drugPgalin Cap. 150mg2020-02-21
    Drug · Prescription · Approval202001236
  • MFDS drugKoetin SR Cap.2020-02-20
    Drug · Prescription · Approval202001223
  • MFDS drugCoxgrin Cap. 100mg2020-01-10
    Drug · Prescription · Approval202000176
  • MFDS drugGloerisone SR Tab.2019-12-24
    Drug · Prescription · Approval201908623
  • MFDS drugDuo Bactam Tab. 500mg2019-11-13
    Drug · Prescription · Approval201907911
  • MFDS drugRasamin Tab. 0.5mg2019-10-30
    Drug · Prescription · Approval201907568
  • MFDS drugRasamin Tab.2019-10-30
    Drug · Prescription · Approval201907569
  • MFDS drugGloTelmitan Tab. 80mg(Telmisartan)Revoked2019-09-10
    Drug · Prescription · Approval201906392
  • MFDS drugGloTelmitan Tab. 40mgRevoked2019-08-21
    Drug · Prescription · Approval201905912
  • MFDS drugNUADIN TAB2019-05-31
    Drug · Prescription · Approval201903636
  • MFDS drugCiloretal SR Cap. 100mg2019-05-31
    Drug · Prescription · Approval201903657
  • MFDS drugCiloretal SR Cap. 200mg2019-05-31
    Drug · Prescription · Approval201903658
  • MFDS drugRaqunin Tab.Revoked2019-05-31
    Drug · Prescription · Approval201903631
  • MFDS drugGuardibone Tab.2019-05-31
    Drug · Prescription · Approval201903619
  • MFDS drugVikaronce Tab. 5/20mg2019-05-29
    Drug · Prescription · Approval201903523
  • MFDS drugVikaronce Tab. 5/40mg2019-05-29
    Drug · Prescription · Approval201903524
  • MFDS drugVikaronce Tab. 10/40mg2019-05-29
    Drug · Prescription · Approval201903525
  • MFDS drugSaporin SR Tab. 300mg2019-05-28
    Drug · Prescription · Approval201903508
  • MFDS drugQ-Phen Inj.2019-05-17
    Drug · Prescription · Approval201903214
  • MFDS drugEyenuri Eye Drops. 0.1%(single use)2019-05-13
    Drug · Prescription · Notification201903078
  • MFDS drugPivaglo Tab. 2mg2019-02-26
    Drug · Prescription · Approval201901224
  • MFDS drugAvogro Tab. 0.5mg2018-07-09
    Drug · Prescription · Approval201802838
  • MFDS drugR-Thioctad Tab. 480mg2017-12-22
    Drug · Prescription · Approval201708551
  • MFDS drugTamisphen 8 hours ER Tab.2017-09-28
    Drug · OTC · Approval201707307
  • MFDS drugGlolion Tab. 10mg2017-07-18
    Drug · Prescription · Approval201705744
  • MFDS drugGuardbone Tab.Revoked2017-07-10
    Drug · Prescription · Approval201705486

Showing the 80 most recent of 208 records.

Clinical trials

data.go.kr

3 MFDS clinical trial authorisations · 2025–2026 (Bioequivalence 2 · Phase 2 1)

  • Phase 2Idetrexed(이데트렉세드)2026-09-11
  • Bioequivalence글로피도그렐정(클로피도그렐황산염)2026-08-26

    2 trial sites

  • Bioequivalence글로피도그렐정(클로피도그렐황산염)2025-10-02

    2 trial sites

Global clinical trials

ClinicalTrials.gov · sponsor-matched

R&D and key agreements

Source: DART corporate disclosure

Idetrexed · FRα(엽산수용체 알파) 발현 종양(난소암·자궁내막암·췌장암·유방암 등) · 임상1상 완료, 국내 임상2상 추진 · An anticancer candidate targeting folate receptor alpha (FRα); Phase 1 showed a significant treatment response in FRα-high patients, and the company licensed it in in February 2026 to pursue a domestic Phase 2 trial.

AGK-102 · TM4SF4 표적 항암 · An antibody-based anticancer candidate targeting TM4SF4.

Key disclosures

KRX KIND via OpenDART

Patents

KIPRIS · applicant-matched
Show 32 more patents

AI reads

MAA server logs · IP-verified
85
Times AI engines pulled Keeps Biopharma Inc.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

0
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

85
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

13
live 0
Last 7 days
67
live 0
Last 30 days
85
live 0
All time
  • OpenAIOAI-SearchBot75
  • PerplexityPerplexityBot6
  • GoogleGoogleOther2
  • AnthropicClaudeBot2

Measured since Aug 27, 2026 · 4 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Keeps Biopharma Inc. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

HANS BIOMED CORPORATION1 shared

KOSDAQ-listed medical device company producing human tissue implants Bella Cell HD and SureFuse.

DONGWHA PHARM.CO.,LTD1 shared

Dongwha Pharm, founded in 1897 and KOSPI-listed in 1976, is a diversified company centered on pharmaceuticals.

WonIk Co.,LTD1 shared

WonIk, founded in 1983 and KOSDAQ-listed in 1997, operates pressure sensor, dermo-cosmetic, and medical device distribution businesses.

BIO-FD&C CO.,LTD.1 shared

Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.

Tego Science, Inc.1 shared

Tego Science makes cell therapies Holoderm and Rosmir, and sells the 3D skin model Neoderm for CDMO and animal-alternative testing.

Chabiotech Co.,Ltd.1 shared

Cord blood storage and cell therapy company that has expanded into global CDMO manufacturing and overseas medical network services.

DaehanPharmaceutical1 shared

Daehan Pharmaceutical, founded in 1963 and KOSDAQ-listed in 1994, manufactures intravenous fluid pharmaceuticals.

Humedix Co., Ltd.1 shared

KOSDAQ-listed aesthetics and CMO company behind the Elravie/Revolax hyaluronic-acid fillers and Leedstox botulinum toxin.

Wonbiogen Co.,Ltd.1 shared

Wonbiogen Co.,Ltd., established September 2018, listed on KOSDAQ in December 2018, manufactures wound dressings and moist wound dressings.

Dong-A Socio Holdings Co.,Ltd1 shared

Founded 1949, KOSPI-listed 1970, Dong-A Socio Holdings makes Bacchus and pharma/non-pharma goods, allied with Meiji Seika on biosimilars.

KOLMAR KOREA CO.,LTD1 shared

Founded and listed on KOSPI in 2012 upon spin-off from the former Kolmar Korea, KOLMAR KOREA runs cosmetics ODM, prescription drugs, and packaging.

DongKookPharmaceuticalCo.,Ltd.1 shared

KOSDAQ-listed comprehensive healthcare and pharmaceutical company behind the gum treatment Insadol and the wound-care ointment Madecassol.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition